Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Hair growth and health are influenced by stress and hormones.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Graying hair happens due to aging and might be delayed by new treatments.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

High-potency steroids or tacrolimus are effective treatments for Erosive Pustular Dermatosis of the Scalp.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

COVID-19 may harm male fertility and damage the reproductive system.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Nail stem cells and Wnt signaling are important for fingertip regeneration but not sufficient for regenerating more complex limb structures.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

Stephen Rothman made important discoveries in dermatology, including the use of PABA in sunscreens, but never profited from his work.